A Form 4 filing submitted on Nov. 9, 2026, reports a trade made on Nov. 5, 2026. This SEC report of insider stock trades lists Edward D. Breen as a director of DuPont de Nemours, Inc. (DD).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-05 |
| Date of Latest Transaction | 2026-11-05 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 89,845 |
| Price | $146.41 |
| Total Transaction Value | $13,154,206.45 |
| Insider | |
| Ticker Symbol | DD |
| Company | DuPont de Nemours, Inc. |
| Insider Name | BREEN EDWARD D |
| Insider Title | Director |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 127,275.57 |
| Position Size Change | 41.38% |
| Filing | |
| Filing Date | 2026-11-09 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was one share sale under SEC transaction code S. The transaction information also points to a related exercise or conversion, which may help explain the sale.
What was the average price of the transaction?
The average sale price was $146.41 per share.
How did this transaction affect the insider's holdings?
After selling 89,845 shares, Edward D. Breen reported 127,275.57 shares remaining, rounded to two decimal places. He sold 41.38% of his reported shares held before the sale.
What's the total transaction value?
The total value was $13,154,206.45 for the single reported sale.
Are there any special circumstances around this transaction?
The sale was identified as linked to an exercise or conversion under code M in the same filing. That link is based on matching share counts. Exercising a stock option means using a right to buy shares at a set price. A conversion changes one kind of investment into another.
The related transaction entry and footnote text were not provided, so the link remains unverified. Matching share counts alone do not confirm that the dates, accounts or types of investments matched, or that the exact shares received were sold. How any exercise was paid for, and whether the sale covered taxes, also remain unknown.
For research purposes only; not investment advice.